Acupuncture for AMD: Treatment Options for Wet and Dry Forms
Age-related macular degeneration — AMD — is one of the leading causes of vision loss in people over 60. There are two main forms, with very different prognoses and very different available treatments. Anyone exploring acupuncture as a complementary approach needs to understand which form they are dealing with, because the conversation about what acupuncture might offer differs significantly between the two.
The two forms in brief
Dry AMD — the more common form, accounting for roughly 85–90% of cases. It progresses slowly. The macula thins, drusen (yellow deposits) accumulate beneath the retina, and central vision gradually deteriorates over years. Conventional medicine has no curative treatment for dry AMD. Lifestyle interventions (the AREDS2 supplement formulation, smoking cessation, dietary changes) can slow progression in some patients. There is no pharmacological treatment that reverses dry AMD damage.
Wet AMD — the less common but more aggressive form. Abnormal blood vessels grow beneath the retina and leak fluid or blood, causing rapid central vision loss. Wet AMD has effective conventional treatment: anti-VEGF injections (ranibizumab, aflibercept, bevacizumab) that suppress the abnormal vessel growth. These injections are typically delivered monthly or every few weeks, indefinitely in many cases. They stabilize most patients and improve vision in a meaningful subset.
Where does acupuncture fit?
The honest answer is: alongside, not instead of, conventional care. For wet AMD patients, this means: continue anti-VEGF injections. They work. Do not skip them to try acupuncture. The role of acupuncture, if any, is as a complementary support — potentially to help with subjective visual quality, fatigue, or general well-being, and possibly to support the slow-progression component of the disease that anti-VEGF injections do not target directly.
For dry AMD patients, where conventional medicine offers only slowing strategies, the case for trying complementary approaches is stronger in the sense that mainstream care is more limited. The Boel Method has accumulated substantial clinical experience with dry AMD patients over four decades. Reports from the Boel clinics and from school-trained practitioners describe stabilization in many cases and measurable visual function improvement in a meaningful subset.
The caveat — and it is important — is that the evidence for these reports is largely clinical, not from large randomized controlled trials. Several smaller studies and case series exist. None of them are definitive in the way that the anti-VEGF trials for wet AMD are definitive. A patient considering this needs to know they are making a reasonable bet on observed clinical experience, not a sure thing.
What an acupuncture protocol for AMD typically looks like
In the Boel Method, AMD is treated with an established protocol. Without going into the specific point selections (which are the school's clinical IP), the structure is:
- Hand and foot microsystem points as the primary therapeutic agent
- Selected periocular and scalp points as adjunct
- Treatments of roughly 20–30 minutes
- Initial series of approximately 10 sessions, often delivered over two to three weeks
- Reassessment after the initial series
- Additional series for responders, typically less intensive maintenance
Other acupuncture approaches use different protocols. Classical TCM treats AMD as a manifestation of underlying organ-system imbalance (typically liver-kidney deficiency) and treats accordingly. Scalp acupuncture targets the occipital "vision area." None of these are wrong; they are different therapeutic models. The Boel Method's edge in this specific condition is the depth of clinical experience accumulated through the school's network.
What outcomes patients describe
Across reports — both from clinical practice and from patient accounts — there are roughly four response patterns:
- Clear improvement. A subset of patients describes measurable improvement in central vision, reading ability, or visual function. This is more common in earlier-stage disease and in patients who begin treatment before significant atrophy has occurred.
- Stabilization. Patients whose disease had been progressing report that progression slows or halts during the treatment course. This pattern is described frequently in dry AMD where progression-tracking is feasible.
- Subjective improvement without measurable change. Some patients describe better visual comfort, less eye fatigue, or improved overall well-being without measurable change on formal vision testing.
- No notable change. A significant fraction of patients see no meaningful response. Late-stage disease, advanced atrophy, and certain disease subtypes appear to respond less consistently.
Honest practitioners will tell prospective patients about this range. Anyone promising guaranteed improvement should be approached with caution.
Coordinating with your ophthalmologist
A patient adding acupuncture to AMD management should keep their ophthalmologist informed. There is no known interaction between acupuncture and anti-VEGF injections. There is no known reason to space treatments apart from injection days, though some practitioners prefer not to treat in the same week as an injection.
What matters more: continue the imaging-based monitoring your ophthalmologist provides. OCT scans, fluorescein angiography where indicated, regular visual acuity testing. These are how you and your doctor will know whether the disease is stable, improving, or progressing. Subjective sense of vision can be misleading in both directions. Objective data is the anchor.
What about supplements?
The AREDS2 formulation — a specific combination of vitamins C and E, zinc, copper, lutein, and zeaxanthin — has evidence for slowing progression in moderate dry AMD. It is reasonable, and your ophthalmologist may have recommended it. Acupuncture and AREDS2 are not mutually exclusive; many patients use both.
Beyond AREDS2, the supplement market is full of products with much weaker evidence. Be cautious. The clinical research on macular health supplements is uneven, and many products marketed to AMD patients are not supported by the evidence they claim.
Realistic framing
If you are dealing with AMD and considering acupuncture, the realistic framing is this: it is one possible component of a comprehensive approach. Continue your ophthalmological care. Take prescribed treatments. Use complementary approaches as additions, not replacements. Assess response honestly. Adjust accordingly.
The Boel Method's specific reputation in this condition is well-earned through decades of clinical experience. Whether it will work for any individual patient is impossible to predict in advance. What is reasonable is to give a properly structured trial — a complete initial series with a properly trained practitioner — and to assess at that point whether continuing is justified.